Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3226-3233

  Van De Stadt, Lotte A ^a   De Koning, Margret H M T ^b   Van De Stadt, Rob J ^b   Wolbink, Gertjan ^a   Dijkmans, Ben A C ^c   Hamann, Dörte ^d   Van Schaardenburg, Dirkjan ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Jan Van Breemen Research Institute/Reade   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sanquin Diagnostiek   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; AUTOANTIGEN; CITRULLINATED PROTEIN ANTIBODY; EPITOPE; FIBRINOGEN; FILAGGRIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROCONVERSION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; EPITOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 80155127957     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30537     Document Type: Article

References (25)

1. Van Venrooij WJ, van Beers JJ, Pruijn GJ,. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008; 1143: 268-85.
2. Lundberg K, Nijenhuis S, Vossenaar E, Palmblad K, van Venrooij W, Klareskog L, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005; 7: R458-67.
3. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
4. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9. (Pubitemid 37280601)
5. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6. (Pubitemid 38198821)
6. Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, et al. Arthritis development in arthralgia patients is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010; 69: 490-4.
7. Van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 2011; 70: 128-33.
8. Hutamekalin P, Saito T, Yamaki K, Mizutani N, Brand DD, Waritani T, et al. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies. J Immunol Methods 2009; 343: 49-55.
9. Van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69: 1554-61.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
11. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63. (Pubitemid 30368225)
12. Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 2007; 56: 3949-52. (Pubitemid 350262321)
13. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36: 2250-63. (Pubitemid 44251769)
14. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, et al. Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008; 58: 3009-19.
15. Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008; 58: 3000-8.
16. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33. (Pubitemid 37255038)
17. Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, et al. Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008; 58: 678-88. (Pubitemid 351364865)
18. Mathsson L, Lampa J, Mullazehi M, Ronnelid J,. Immune complexes from rheumatoid arthritis synovial fluid induce FcγRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-α by peripheral blood mononuclear cells. Arthritis Res Ther 2006; 8: R64.
19. Mullazehi M, Mathsson L, Lampa J, Ronnelid J,. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor α, interleukin-1β, and interleukin-8 from peripheral blood monocytes via Fcγ receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis. Arthritis Rheum 2006; 54: 1759-71. (Pubitemid 43877925)
20. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R94.
21. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, et al. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 2010; 62: 2239-48.
22. Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, Wang J, et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 2010; 62: 1620-9.
23. Imafuku Y, Yoshida H, Yamada Y,. Reactivity of agalactosyl IgG with rheumatoid factor. Clin Chim Acta 2003; 334: 217-23. (Pubitemid 36836078)
24. Soltys AJ, Hay FC, Bond A, Axford JS, Jones MG, Randen I, et al. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994; 40: 135-43. (Pubitemid 24251729)
25. Van Venrooij WJ, Pruijn GJ,. An important step towards completing the rheumatoid arthritis cycle. Arthritis Res Ther 2008; 10: 117.